Tamagnone, Luca
 Distribuzione geografica
Continente #
NA - Nord America 1.986
EU - Europa 1.702
AS - Asia 758
SA - Sud America 8
Continente sconosciuto - Info sul continente non disponibili 5
AF - Africa 1
Totale 4.460
Nazione #
US - Stati Uniti d'America 1.961
SE - Svezia 642
IE - Irlanda 345
CN - Cina 299
IT - Italia 260
SG - Singapore 223
FR - Francia 215
ID - Indonesia 115
DE - Germania 52
GB - Regno Unito 51
RU - Federazione Russa 48
IL - Israele 28
CA - Canada 24
NL - Olanda 21
HK - Hong Kong 19
TR - Turchia 18
UA - Ucraina 16
IN - India 15
CZ - Repubblica Ceca 13
JP - Giappone 12
IR - Iran 10
MY - Malesia 10
FI - Finlandia 9
CH - Svizzera 5
ES - Italia 5
EU - Europa 5
AR - Argentina 4
BE - Belgio 4
RO - Romania 4
KR - Corea 3
MK - Macedonia 3
AT - Austria 2
BG - Bulgaria 2
GR - Grecia 2
SY - Repubblica araba siriana 2
BD - Bangladesh 1
BR - Brasile 1
CL - Cile 1
CO - Colombia 1
DK - Danimarca 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
MX - Messico 1
PE - Perù 1
PH - Filippine 1
PL - Polonia 1
PT - Portogallo 1
ZA - Sudafrica 1
Totale 4.460
Città #
Menlo Park 532
Ashburn 231
Dublin 179
Singapore 171
Chandler 149
Jakarta 115
Princeton 104
Wilmington 78
Beijing 76
Cattolica 76
Milan 75
San Mateo 72
Redwood City 65
Dearborn 56
Boston 49
Rome 35
Moscow 29
New York 28
Nanjing 26
Chicago 24
Norwalk 24
Washington 19
Fairfield 17
Hangzhou 17
Hong Kong 14
Andover 13
Shanghai 13
Guangzhou 12
Mountain View 12
Seattle 12
Tel Aviv 11
Houston 10
Los Angeles 10
Nanchang 10
Puchong Batu Dua Belas 10
Toronto 10
Woodbridge 10
Hefei 9
Jacksonville 9
Ann Arbor 8
Busto Arsizio 8
London 8
Naaldwijk 8
Tokyo 8
Changsha 7
Kunming 7
Marseille 7
Riva 7
Frankfurt am Main 6
Hebei 6
Lappeenranta 6
Kocaeli 5
Monza 5
Pune 5
Ramat Gan 5
Santa Clara 5
Shenyang 5
Turin 5
Zurich 5
Amsterdam 4
Brno 4
Brussels 4
Cambridge 4
Chengdu 4
Izmir 4
Jiaxing 4
Jinan 4
Manchester 4
New Haven 4
Ottawa 4
Redmond 4
Renton 4
San Diego 4
Tianjin 4
Austin 3
Boardman 3
Bremen 3
Carlsbad 3
Chiswick 3
Clinton 3
Dallas 3
Delhi 3
Edinburgh 3
Haifa 3
Helsinki 3
Kish 3
Lyon 3
Newcastle Upon Tyne 3
North Aurora 3
Orta 3
Prague 3
Queens Village 3
Renon 3
Riverside 3
Stockholm 3
Tabriz 3
Tappahannock 3
Alexandria 2
Athens 2
Auburn Hills 2
Totale 2.673
Nome #
A Novel Prognostic Marker for Primary CNS Lymphoma: Lactate Dehydrogenase-to-Lymphocyte Ratio Improves Stratification of Patients Within the Low and Intermediate MSKCC Risk Groups 852
Endothelial Cell Metabolism in Vascular Functions 105
LPHN2 inhibits vascular permeability by differential control of endothelial cell adhesion 85
Semaphorins: Missing Signals in Age-dependent Alteration of Neuromuscular Junctions and Skeletal Muscle Regeneration 84
Taurine Administration Counteracts Aging-Associated Impingement of Skeletal Muscle Regeneration by Reducing Inflammation and Oxidative Stress 80
NON-NATURAL SEMAPHORINS 3 AND THEIR MEDICAL USE 73
NOVEL MEMBERS OF THE PLEXIN FAMILY AND USES THEREOF 71
Retinoic acid synergizes with the unfolded protein response and oxidative stress to induce cell death in FLT3-ITD+ AML. 61
Plexin‑Bs enhance their GAP activity with a novel activation switch loop generating a cooperative enzyme. 61
Transcriptome integration analysis and specific diagnosis model construction for Hodgkin's lymphoma, diffuse large B-cell lymphoma, and mantle cell lymphoma 59
Antibody-Feeding Assay: A Method to Track the Internalization of Neuropilin-1 and Other Cell Surface Receptors 58
Semaphorins as emerging clinical biomarkers and therapeutic targets in cancer 58
Neuropilin-1 Expression Associates with Poor Prognosis in HNSCC and Elicits EGFR Activation upon CDDP-Induced Cytotoxic Stress 57
Neuropilin-1 upregulation elicits adaptive resistance to oncogene-targeted therapies 55
Semaphorins in health and disease 54
A prognostic model for melanoma patients on the basis of immune-related lncRNAs 54
PlexinA4 mediates cytotoxic T cell trafficking and exclusion in cancer 53
Autocrine Signaling of NRP1 Ligand Galectin-1 Elicits Resistance to BRAF-Targeted Therapy in Melanoma Cells 52
Neuropilins Controlling Cancer Therapy Responsiveness 51
Rhomboid-Like-2 Intramembrane Protease Mediates Metalloprotease-Independent Regulation of Cadherins 47
A rationally designed NRP1-independent superagonist SEMA3A mutant is an effective anticancer agent 45
To Die or Not to Die: Sema3E Rules the Game 45
Downregulating neuropilin-2 triggers a novel mechanism enabling EGFR-dependent resistance to oncogene-targeted therapies 42
Transmembrane semaphorins, forward and reverse signaling: Have a look both ways 42
Semaphorin Signaling in Cancer-Associated Inflammation. 42
Semaphorins and Their Receptors in Hematological Malignancies. 42
Long non-coding RNA p10247, high expressed in breast cancer (lncRNA-BCHE), is correlated with metastasis 41
Bad vessels beware! Semaphorins will sort you out! 40
Semaphorin 4A Stabilizes Human Regulatory T Cell Phenotype via Plexin B1 40
Restricted innervation of uterus and placenta during pregnancy: evidence for a role of the repelling signal Semaphorin 3A. 40
Semaphorins as Regulators of Phenotypic Plasticity and Functional Reprogramming of Cancer Cells 38
Taming the Notch Transcriptional Regulator for Cancer Therapy 37
Transmembrane semaphorins: Multimodal signaling cues in development and cancer 37
Reverse signaling by semaphorin 4C elicits SMAD1/5- and ID1/3-dependent invasive reprogramming in cancer cells. 37
PlexinD1 is a novel transcriptional target and effector of notch signaling in cancer cells 36
Induction of epithelial tubules by growth factor HGF depends on the STAT pathway 35
SEMA6C: a novel adhesion-independent FAK and YAP activator, required for cancer cell viability and growth 34
Semaphorin7A regulates neuroglial plasticity in the adult hypothalamic median eminence. 34
Message in a Bottle: Endothelial Cell Regulation by Extracellular Vesicles 33
Hemodialysis stimulates hepatocyte growth factor release 31
Sema4C-Plexin B2 signalling modulates ureteric branching in developing kidney 31
p190 Rho-GTPase activating protein associates with plexins and it is required for semaphorin signalling 31
Targeting Neuropilin-1 with Nanobodies Reduces Colorectal Carcinoma Development 31
Hepatocyte growth factor and its receptor, the tyrosine kinase encoded by the c-MET proto-oncogene 30
Sema4C/PlexinB2 signaling controls breast cancer cell growth, hormonal dependence and tumorigenic potential 30
The tetraspanin CD151 is required for Met-dependent signaling and tumor cell growth 30
The semaphorin 4D-plexin-B signalling complex regulates dendritic and axonal complexity in developing neurons via diverse pathways. 30
BMX, a novel nonreceptor tyrosine kinase gene of the BTK/ITK/TEC/TXK family located in chromosome Xp22.2 30
Sema4D induces angiogenesis through Met recruitment by Plexin B1 30
Cross-talk between vascular endothelial growth factor and semaphorin-3A pathway in the regulation of normal and malignant mesothelial cell proliferation 30
L858R emerges as a potential biomarker predicting response of lung cancer models to anti-EGFR antibodies: Comparison of osimertinib vs. cetuximab 30
Mutated axon guidance gene PLXNB2 sustains growth and invasiveness of stem cells isolated from cancers of unknown primary 29
Class 3 semaphorins control vascular morphogenesis by inhibiting integrin function 29
Molecular profiling of the "plexinome" in melanoma and pancreatic cancer 29
Structure and function of the intracellular region of the plexin-B1 transmembrane receptor 29
Semaphorin Signals on the Road of Endothelial Tip Cells 29
Tumor angiogenesis and progression are enhanced by Sema4D produced by tumor-associated macrophages 29
CD38 and CD100 lead a network of surface receptors relaying positive signals for B-CLL growth and survival 29
To move or not to move? Semaphorin signalling in cell migration 28
Semaphorin receptors meet receptor tyrosine kinases on the way of tumor progression 28
Impeding Macrophage Entry into Hypoxic Tumor Areas by Sema3A/Nrp1 Signaling Blockade Inhibits Angiogenesis and Restores Antitumor Immunity 28
Emerging Role of Semaphorins as Major Regulatory Signals and Potential Therapeutic Targets in Cancer 27
Targetin Semaphorin 4D in Cancer: A Look from Different Perspectives 27
Brain Endothelial Cells Control Fertility through Ovarian-Steroid-Dependent Release of Semaphorin 3A 27
Sema3E-Plexin D1 signaling drives human cancer cell invasiveness and metastatic spreading in mice 27
Signalling by semaphorin receptors: Cell guidance and beyond 26
Plexin-B1 plays a redundant role during mouse development and in tumour angiogenesis 26
Experimental approaches for studying semaphorin signals in tumor growth and metastasis in mouse models 26
The human ryk cDNA sequence predicts a protein containing two putative transmembrane segments and a tyrosine kinase catalytic domain 26
Functional regulation of semaphorin receptors by proprotein convertases 26
Overexpression of GAP-43 modifies the distribution of the receptors for myelin-associated growth-inhibitory proteins in injured Purkinje axons 26
Co-expression of plexin-B1 and Met in human breast and ovary tumours enhances the risk of progression 26
Differential expression of paralog RNA binding proteins establishes a dynamic splicing program required for normal cerebral cortex development 25
Semaphorin-3A is expressed by tumor cells and alters T-cell signal transduction and function 25
Tyrosine phosphorylation in semaphorin signalling: shifting into overdrive 25
Multifaceted role of neuropilins in cancer 25
Semaphorin signals in cell adhesion and cell migration: functional role and molecular mechanisms 24
Mutant Met-mediated transformation is ligand-dependent and can be inhibited by HGF antagonists 24
Plexin-B3 is a functional receptor for semaphorin 5A 24
Tumour growth inhibition and anti-metastatic activity of a mutated furin-resistant Semaphorin 3E isoform 24
Evidence for autocrine activation of a tyrosine kinase in a human gastric carcinoma cell line 24
Semaphorin 4D regulates gonadotropin hormone-releasing hormone-1 neuronal migration through PlexinB1-Met complex 24
The semaphorin 4D receptor controls invasive growth by coupling with Met 24
Systemic and targeted delivery of semaphorin 3A inhibits tumor angiogenesis and progression in mouse tumor models 24
Extracellular proteolytic cleavage by urokinase is required for activation of hepatocyte growth factor/scatter factor 23
Plasminogen-related growth factor and semaphorin receptors: A gene superfamily controlling invasive growth 23
A novel prognostic model based on pretreatment serum albumin and ECOG PS for primary CNS lymphoma: an international, multi-center study 22
Semaphorin pathways orchestrate osteogenesis 22
The tumor suppressor semaphorin 3B triggers a prometastatic program mediated by interleukin 8 and the tumor microenvironment 22
A family of transmembrane proteins with homology to the MET-hepatocyte growth factor receptor 22
Semaphorin3A signaling controls Fas (CD95)-mediated apoptosis by promoting Fas translocation into lipid rafts 21
Plexin A is a neuronal semaphorin receptor that controls axon guidance 21
Semaphorin signaling in cancer cells and in cells of the tumor microenvironment - Two sides of a coin 21
Plexin signaling hampers integrin-based adhesion, leading to Rho-kinase independent cell rounding, and inhibiting lamellipodia extension and cell motility 21
Plexins are a large family of receptors for transmembrane, secreted, and GPI-anchored semaphorins in vertebrates 21
Proteolytic processing converts the repelling signal Sema3E into an inducer of invasive growth and lung metastasis 21
Plexin-B2, but not plexin-B1, critically modulates neuronal migration and patterning of the developing nervous system in vivo 21
Sorcin promotes migration in cancer and regulates the EGF-dependent EGFR signaling pathways 20
Regulated surface expression and shedding support a dual role for semaphorin 4D in platelet responses to vascular injury 20
The transmembrane protein off-track associates with plexins and functions downstream of semaphorin signaling during axon guidance 20
Totale 4.384
Categoria #
all - tutte 30.327
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.327


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020285 0 0 0 0 37 69 23 46 30 29 40 11
2020/2021274 34 3 18 9 33 24 26 11 44 29 26 17
2021/20221.413 73 3 780 62 59 25 24 111 29 31 118 98
2022/20231.086 156 239 146 45 68 134 27 117 73 24 39 18
2023/2024947 21 235 100 30 51 158 43 39 11 26 97 136
2024/2025321 35 15 142 52 77 0 0 0 0 0 0 0
Totale 4.651